CA IX-targeted Ag<sub>2</sub>S quantum dots bioprobe for NIR-II imaging-guided hypoxia tumor chemo-photothermal therapy

Xinyue Cui; Zhuang Hu; Ruihan Li; Peng Jiang; Yongchang Wei; Zilin Chen

doi:10.1016/j.jpha.2024.100969

Volume 14 Issue 6

Jun. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2024 > 14(6): 100969

Xinyue Cui, Zhuang Hu, Ruihan Li, Peng Jiang, Yongchang Wei, Zilin Chen. CA IX-targeted Ag2S quantum dots bioprobe for NIR-II imaging-guided hypoxia tumor chemo-photothermal therapy[J]. Journal of Pharmaceutical Analysis, 2024, 14(6): 100969. doi: 10.1016/j.jpha.2024.100969

Citation:

Xinyue Cui, Zhuang Hu, Ruihan Li, Peng Jiang, Yongchang Wei, Zilin Chen. CA IX-targeted Ag₂S quantum dots bioprobe for NIR-II imaging-guided hypoxia tumor chemo-photothermal therapy[J]. Journal of Pharmaceutical Analysis, 2024, 14(6): 100969. doi: 10.1016/j.jpha.2024.100969

Citation:

PDF( 4620 KB)

CA IX-targeted Ag₂S quantum dots bioprobe for NIR-II imaging-guided hypoxia tumor chemo-photothermal therapy

doi: 10.1016/j.jpha.2024.100969

Xinyue Cui^a,b,
Zhuang Hu^a,b,
Ruihan Li^a,b,
Peng Jiang^a,b,
Yongchang Wei^{a
,
,},
Zilin Chen^{a,b
,
,}

a. Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University and School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China;
b. Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, Hubei Province Engineering and Technology Research Center for Fluorinated Pharmaceuticals, Wuhan, 430071, China

Funds:

This work was supported by the National Natural Science Foundation of China (Grant Nos: 82073808 and 82273885).

Received Date: Sep. 20, 2023
Accepted Date: Mar. 20, 2024
Rev Recd Date: Feb. 05, 2024
Publish Date: Mar. 22, 2024

Abstract

Abstract

Hypoxia is the common characteristic of almost all solid tumors, which prevents therapeutic drugs from reaching the tumors. Therefore, the development of new targeted agents for the accurate diagnosis of hypoxia tumors is widely concerned. As carbonic anhydrase IX (CA IX) is abundantly distributed on the hypoxia tumor cells, it is considered as a potential tumor biomarker. 4-(2-Aminoethyl) benzenesulfonamide (ABS) as a CA IX inhibitor has inherent inhibitory activity and good targeting effect. In this study, Ag₂S quantum dots (QDs) were used as the carrier to prepare a novel diagnostic and therapeutic bioprobe (Ag₂S@polyethylene glycol (PEG)-ABS) through ligand exchange and amide condensation reaction. Ag₂S@PEG-ABS can selectively target tumors by surface-modified ABS and achieve accurate tumor imaging by the near infrared-II (NIR-II) fluorescence characteristics of Ag₂S QDs. PEG modification of Ag₂S QDs greatly improves its water solubility and stability, and therefore achieves high photothermal stability and high photothermal conversion efficiency (PCE) of 45.17%. Under laser irradiation, Ag₂S@PEG-ABS has powerful photothermal and inherent antitumor combinations on colon cancer cells (CT-26) in vitro. It also has been proved that Ag₂S@PEG-ABS can realize the effective treatment of hypoxia tumors in vivo and show good biocompatibility. Therefore, it is a new efficient integrated platform for the diagnosis and treatment of hypoxia tumors.
- CA IX-targeted,
- Hypoxia tumor combination therapy,
- NIR-II imaging,
- Photothermal effect

FullText(HTML)

References(53)

References

[1]	H. Sung, J. Ferlay, R.L. Siegel, et al., Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin. 71(2021)209-249.
[2]	N. Keum, E. Giovannucci, Global burden of colorectal cancer:Emerging trends, risk factors and prevention strategies, Nat. Rev. Gastroenterol. Hepatol. 16(2019)713-732.
[3]	B. Muz, P. de la Puente, F. Azab, et al., The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy, Hypoxia (Auckl.)3(2015)83-92.
[4]	J. Zhang, L. Li, Stem cell niche:Microenvironment and beyond, J. Biol. Chem. 283(2008)9499-9503.
[5]	B. Yang, F. Meng, J. Zhang, et al., Engineered drug delivery nanosystems for tumor microenvironment normalization therapy, Nano Today 49(2023), 101766.
[6]	C.T. Supuran, V. Alterio, A. Di Fiore, et al., Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells:Three for the price of one, Med. Res. Rev. 38(2018)1799-1836.
[7]	Y. Lou, P.C. McDonald, A. Oloumi, et al., Targeting tumor hypoxia:Suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors, Cancer Res. 71(2011)3364-3376.
[8]	A. Cecchi, A. Hulikova, J. Pastorek, et al., Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors, J. Med. Chem. 48(2005)4834-4841.
[9]	A. Queen, H.N. Bhutto, M. Yousuf, et al., Carbonic anhydrase IX:A tumor acidification switch in heterogeneity and chemokine regulation, Semin. Cancer Biol. 86(2022)899-913.
[10]	P. Vermylen, C. Roufosse, A. Burny, et al., Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma, Eur. Respir. J. 14(1999)806-811.
[11]	A. Janoniene, Z. Liu, L. Baranauskiene, et al., A versatile carbonic anhydrase IX targeting ligand-functionalized porous silicon nanoplatform for dual hypoxia cancer therapy and imaging, ACS Appl. Mater. Interfaces 9(2017)13976-13987.
[12]	S. Cazzamalli, B. Ziffels, F. Widmayer, et al., Enhanced therapeutic activity of non-internalizing small-molecule-drug conjugates targeting carbonic anhydrase IX in combination with targeted interleukin-2, Clin. Cancer. Res. 24(2018)3656-3667.
[13]	G. Hong, A.L. Antaris, H. Dai, Near-infrared fluorophores for biomedical imaging, Nat. Biomed. Eng. 1(2017), 0010.
[14]	Y. Yang, Y. Xie, F. Zhang, Second near-infrared window fluorescence nanoprobes for deep-tissue in vivo multiplexed bioimaging, Adv. Drug Deliv. Rev. 193(2023), 114697.
[15]	H. Wan, J. Yue, S. Zhu, et al., A bright organic NIR-II nanofluorophore for three-dimensional imaging into biological tissues, Nat. Commun. 9(2018), 1171.
[16]	Y. Fan, F. Zhang, A new generation of NIR-II probes:Lanthanide-based nanocrystals for bioimaging and biosensing, Adv. Opt. Mater. 7(2019), 1801417.
[17]	S. He, J. Song, J. Qu, et al., Crucial breakthrough of second near-infrared biological window fluorophores:Design and synthesis toward multimodal imaging and theranostics, Chem. Soc. Rev. 47(2018)4258-4278.
[18]	R. Huo, Y. Liu, H. Xu, et al., Associations between carotid atherosclerotic plaque characteristics determined by magnetic resonance imaging and improvement of cognition in patients undergoing carotid endarterectomy, Quant. Imaging Med. Surg. 12(2022)2891-2903.
[19]	H. Xu, H. Wang, W. Zhao, et al., SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma, Theranostics 10(2020)5671-5686.
[20]	X. Hu, L. Zhou, X. Wu, et al., Review on near-field detection technology in the biomedical field, Adv. Photon. Nexus 2(2023), 044002.
[21]	J.M. Pietryga, R.D. Schaller, D. Werder, et al., Pushing the band gap envelope:Mid-infrared emitting colloidal PbSe quantum dots, J. Am. Chem. Soc. 126(2004)11752-11753.
[22]	W. Lei, J. Antoszewski, L. Faraone, Progress, challenges, and opportunities for HgCdTe infrared materials and detectors, Appl. Phys. Rev. 2(2015), 041303.
[23]	C. Ding, Y. Huang, Z. Shen, et al., Synthesis and bioapplications of Ag₂S quantum dots with near-infrared fluorescence, Adv. Mater. 33(2021), 2007768.
[24]	B. Purushothaman, J.M. Song, Ag₂S quantum dot theragnostics, Biomater. Sci. 9(2021)51-69.
[25]	Y. Du, B. Xu, T. Fu, et al., Near-infrared photoluminescent Ag₂S quantum dots from a single source precursor, J. Am. Chem. Soc. 132(2010)1470-1471.
[26]	P. Awasthi, X. An, J. Xiang, et al., Facile synthesis of noncytotoxic PEGylated dendrimer encapsulated silver sulfide quantum dots for NIR-II biological imaging, Nanoscale 12(2020)5678-5684.
[27]	S. Qu, Q. Jia, Z. Li, et al., Chiral NIR-II fluorescent Ag₂S quantum dots with stereospecific biological interactions and tumor accumulation behaviors, Sci. Bull. 67(2022)1274-1283.
[28]	F. Hu, C. Li, Y. Zhang, et al., Real-time in vivo visualization of tumor therapy by a near-infrared-II Ag₂S quantum dot-based theranostic nanoplatform, Nano Res. 8(2015)1637-1647.
[29]	C. Li, X. Yang, J. An, et al., Red blood cell membrane-enveloped O₂ self-supplementing biomimetic nanoparticles for tumor imaging-guided enhanced sonodynamic therapy, Theranostics 10(2020)867-879.
[30]	D. Zhao, J. Yang, R. Xia, et al., High quantum yield Ag₂S quantum dot@polypeptide-engineered hybrid nanogels for targeted second near-infrared fluorescence/photoacoustic imaging and photothermal therapy, Chem. Commun.(Camb.)54(2018)527-530.
[31]	R. Tang, J. Xue, B. Xu, et al., Tunable ultrasmall visible-to-extended near-infrared emitting silver sulfide quantum dots for integrin-targeted cancer imaging, ACS Nano 9(2015)220-230.
[32]	Z. Wang, Y. Ma, X. Yu, et al., Targeting CXCR4-CXCL12 axis for visualizing, predicting, and inhibiting breast cancer metastasis with theranostic AMD3100-Ag₂S quantum dot probe, Adv. Funct. Mater. 28(2018), 1800732.
[33]	F.D. Duman, M. Erkisa, R. Khodadust, et al., Folic acid-conjugated cationic Ag₂S quantum dots for optical imaging and selective doxorubicin delivery to HeLa cells, Nanomedicine (Lond.)12(2017)2319-2333.
[34]	G. Chen, F. Tian, Y. Zhang, et al., Tracking of transplanted human mesenchymal stem cells in living mice using near-infrared Ag₂S quantum dots, Adv. Funct. Mater. 24(2014)2481-2488.
[35]	E. Sanchez Armengol, A. Unterweger, F. Laffleur, PEGylated drug delivery systems in the pharmaceutical field:Past, present and future perspective, Drug Dev. Ind. Pharm. 48(2022)129-139.
[36]	S.D. Li, L. Huang, Stealth nanoparticles:High density but sheddable PEG is a key for tumor targeting, J. Control. Release 145(2010)178-181.
[37]	H. Wang, J. Chang, M. Shi, et al., A dual-targeted organic photothermal agent for enhanced photothermal therapy, Angew. Chem. Int. Ed. Engl. 58(2019)1057-1061.
[38]	M. Abbas, Q. Zou, S. Li, et al., Self-assembled peptide-and protein-based nanomaterials for antitumor photodynamic and photothermal therapy, Adv. Mater. 29(2017), 1605021.
[39]	J. Lou, A. Heater, G. Zheng, Improving the delivery of drugs and nucleic acids to T cells using nanotechnology, Small Struct. 2(2021), 2100026.
[40]	H. Sun, Q. Zhang, J. Li, et al., Near-infrared photoactivated nanomedicines for photothermal synergistic cancer therapy, Nano Today 37(2021), 101073.
[41]	Y. Zhao, T. Zhao, Y. Cao, et al., Temperature-sensitive lipid-coated carbon nanotubes for synergistic photothermal therapy and gene therapy, ACS Nano 15(2021)6517-6529.
[42]	D. Zhao, X. Yang, X. Hou, et al., In situ aqueous synthesis of genetically engineered polypeptide-capped Ag₂S quantum dots for second near-infrared fluorescence/photoacoustic imaging and photothermal therapy, J. Mater. Chem. B 7(2019)2484-2492.
[43]	S. Sindhwani, A.M. Syed, J. Ngai, et al., The entry of nanoparticles into solid tumours, Nat. Mater. 19(2020)566-575.
[44]	M. Landgraf, C.A. Lahr, I. Kaur, et al., Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasis, Biomaterials 240(2020), 119791.
[45]	Z. Hu, R. Li, X. Cui, et al., A pH-sensitive carbonic anhydrase IX-targeted near-infrared probe for fluorescent sensing and imaging of hypoxic osteosarcoma, Sens. Actuat. B Chem. 379(2023), 133171.
[46]	X. Liao, Y. Hong, Z. Chen, Identification and quantification of the bioactive components in Osmanthus fragrans roots by HPLC-MS/MS, J. Pharm. Anal. 11(2021)299-307.
[47]	N. He, Z. Li, C. Hu, et al., In situ synthesis of a spherical covalent organic framework as a stationary phase for capillary electrochromatography, J. Pharm. Anal. 12(2022)610-616.
[48]	Y. Liu, N. He, Y. Lu, et al., A benzenesulfonic acid-modified organic polymer monolithic column with reversed-phase/hydrophilic bifunctional selectivity for capillary electrochromatography, J. Pharm. Anal. 13(2023)209-215.
[49]	Z. Hu, R. Li, X. Cui, et al., Albumin-based cyanine crizotinib conjugate nanoparticles for NIR-II imaging-guided synergistic chemophototherapy, ACS Appl. Mater. Interfaces 15(2023)33890-33902.
[50]	Z. Hu, R. Li, X. Cui, et al., Tailoring albumin-based theranostic PROTACs nanoparticles for enhanced NIR-II bioimaging and synergistic cancer chemo-phototherapy, Chem. Eng. J. 469(2023), 143883.
[51]	P. Jiang, C. Zhu, Z. Zhang, et al., Water-soluble Ag₂S quantum dots for near-infrared fluorescence imaging in vivo, Biomaterials 33(2012)5130-5135.
[52]	A.L. Antaris, H. Chen, K. Cheng, et al., A small-molecule dye for NIR-II imaging, Nat. Mater. 15(2016)235-242.
[53]	Y. Shao, B. Liu, Z. Di, et al., Engineering of upconverted metal-organic frameworks for near-infrared light-triggered combinational photodynamic/chemo-/immunotherapy against hypoxic tumors, J. Am. Chem. Soc. 142(2020)3939-3946.